Aβ oligomers peak in early stages of Alzheimer's disease preceding tau pathology.

Although Aβ and tau oligomer levels showed a highly significant correlation (Spearman r = .541, p = 2.7 × 10 −41 ), no increase of tau oligomer levels regarding the disease stage was observed (Figure 1B ).

also in 33,666 other papers